![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
One-year results of the Global Phase 2b randomized placebo-controlled ARREST Trial of Aramchol, a Stearoyl CoA Desaturasemodulator in NASH patients
|
|
|
Reported by Jules Levin
AASLD 2018 Nov 9-13 SF
V. Ratziu, L. de Guevara, R. Safadi, F. Poordad, F. Fuster, J. Flores-Figueroa, S.A. Harrison, M. Arrese, S. Fargion, D. Ben Bashat, C. Lackner, T. Gorfine, S. Kadosh, R. Oren, R. Loomba and A.J. Sanyalon behalf of the ARREST investigator study group
![1212181](../images%20/121218/121218-4/1212181.gif)
![1212182](../images%20/121218/121218-4/1212182.gif)
![1212184](../images%20/121218/121218-4/1212184.gif)
![1212186](../images%20/121218/121218-4/1212186.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|